DJIA 18,179.38 -109.25 -0.60%
NASDAQ 4,969.81 -38.28 -0.76%
S&P 500 2,100.93 -16.46 -0.78%
market minute promo

BioTime, Inc. (NYSEMKT: BTX)

4.24 -0.01 (-0.24%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

BTX $4.24 -0.24%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $4.25
Previous Close $4.25
Daily Range $4.20 - $4.25
52-Week Range $2.21 - $4.64
Market Cap $352.4M
P/E Ratio -5.52
Dividend (Yield) $0.00 (0.0%)
Volume 36,370
Average Daily Volume 153,800
Current FY EPS $0.00

Sector

Healthcare

Industry

Drug Makers

BioTime, Inc. (BTX) Description

BioTime Inc. is engaged in the business of developing blood plasma volume expanders and related products and stem cell related products and technology for diagnostic therapeutic and research use. Website: http://www.biotimeinc.com/

News & Commentary Rss Feed

The Small-Cap Stock I'm Watching in 2015

Three Motley Fools tell investors which small-cap stocks they'll be watching in 2015.

Asterias Biotherapeutics Announces Public Offering of Common Stock

BioTime, Inc.: Following The Smart Money

BioTime, Inc. Subsidiary OncoCyte Corporation Completes Initial Enrollment of Clinical Study of Urin

BioTime, Inc. Subsidiary OncoCyte Corporation Completes Initial Enrollment of Clinical Study of Urine-Based Bladder Cancer Diagnostic

UPDATE: BioTime Appoints Angus C. Russell To Bd Of Directors

Commit To Purchase BioTime At $2.50, Earn 14.5% Annualized Using Options

BioTime Harnesses Geron's Stem Cell Technology And Its Founder; Is That Enough To Survive The Biotec

BioTime Harnesses Geron's Stem Cell Technology And Its Founder; Is That Enough To Survive The Biotech Revolution?

A Timely Interview With BioTime's CEO And His Chief Commercial Officer

UPDATE: BioTime Receives Authorization To Begin Pivotal Human Clinical Trial Of Renevia In Europe

BioTime: Recent News Hints At Positive Developments

See More BTX News...

BTX's Top Competitors

BTX $4.24 (-0.24%)
Current stock: BTX
AMGN $157.83 (-1.13%)
Current stock: AMGN
GILD $102.33 (-1.44%)
Current stock: GILD
BIIB $408.07 (-1.86%)
Current stock: BIIB